Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 4426

BillFederalSenateIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
About This Bill
Committee
Latest Action · May 23, 2024
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
May 23, 2024
Cosponsors (11)
6D 5R
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.